Fig. 1 (abstract P453).From: 32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Part TwoCombination therapy of PEGPH20 with Cy/GVAX improves immune cell infiltration and survival in a PDAC mouse modelBack to article page